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Abstract: The author designed a direct injection method of endoscopic injection 
sclerotherapy (EIS) for gastric varices with a newly developed technique for controlling 
bleeding from the punctured site， and subsequently used it for prophylactic treatment in 10 
cases. EIS was performed under X -ray monitoring in the absence of a balloon， and 5 % 
ethanolamine oleate containing 49 % Iopamidol was used as the sclerosant. A twenty-five 
gauge needle wearing an outer tube was used for the puncture. After injection of sclerosant， 
thrombin was poured into the outer tube while pulling out the needle. After the needle was 
pulled out， thrombin was sprayed over the punctured site when bleeding was negligible， and 
if bleeding was stil noted， 1-2 ml of ethanol was injected into the varices. Bleeding from 
the punctured site was sl.ccessfully controlled by spraying thrombin ot ethanol injection 
No other serious complications were observed. All varices treated by this technique were 
flattened or had disappeared after EIS， and since then no recurrent growth or bleeding has 
been observed. It is suggested that this direct injection method of EIS is a safe， less invasive 
and effective prophylactic treatment for gastric varices. 
Index Terms 
endoscopic injection sclerotherapy， gastric varices， prophylactic therapy， ethanolamine 
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INTRODUCTION 
Endoscopic injection sclerotherapy (EIS) is a useful prophylactic method for the prevention 
of recurrent bleeding from esophageal varices involved in patients with portal hypertension1，21. 
Gastric varice are also involved in these patients， and occasionally associated with serious 
bleeding31 • However， the prophylactic treatment of gastric varices by EIS is uncommon， 
although EIS is used for acute bleeding gastric varices3-51， because the safety and efficacy of 
the prophylactic use of EIS for gastric varices has not been established. Several problems are 
responsible for the difficulty in prophylactic use of EIS for gastric varices. First， the injected 
sclerosant apparently enters the systemic circulation easily because intravariceal blood-flow is 
hardly interrupted. Thus， the formation of a thrombus sufficient to give sclerosing effect may 
not be obtainable， and complications in the systemic circulation may occur. Second， a method 
for prevention and control of bleeding from the punctured site has not been established. In this 
study， 1 designed a direct injection method of EIS for gastric varices with a newly developed 
technique for controlling bleeding from the punctured site， and subsequently used it for 
prophylactic treatment. The results revealed thp.t the method is safe and effective for prophy-
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lactic treatment of gastric varices. 
P ATIENTS AND METHODS 
Patients 
Ten patients with risky gastric varices (nodular form， tumorous form varices and/or varices 
with red marking or er'osion) involved in liver cirrhosis were entered in this study with their 
informed consent. These cases were not selected but al the cases 1 have had since this study 
was begun. The patients' characteristics and backgrounds are shown in Table 1. Special 
medications such asβblocking agents were not administered to these patients. 
Table 1. Characteristics and backgrounds of pati巴nts
Case NO. 
1 2 3 4 5 6 7 8 9 10 
Ag巴 (years) 53 66 59 51 58 40 64 52 58 62 
Sex (M or F) M F M M F M M M M M 
Cause of cirrhosis 
Alcoholic + 十 + 十 十
Others + 十 十 + 十
Concomitant hepatoma + + + + 
Child's grading C B A A B B C B A C 
Liver function 
Albumin (g/ dl) 2.0 3.3 3.3 3.5 3.1 3.5 2.9 3.0 3.5 2.5 
Bilirubin (mg/dl) 2.2 0.9 1.4 0.8 1.4 2.1 3.9 2.4 1.7 3.2 
Prothrombin time 0.5 1.5 3.4 0.5 2.4 0.1 3.0 2.7 -0.6 1. 8 
(sec over control) 
Previous variceal bl巴eding(n) 1 2 3 1 1 1 
Previous EIS(n) 3 4 10 6 6 2 3 
Previous variceal bl巴巴dingsar巴 alfrom esophageal varices. 
Pr巴viousscleroth巴rapl巴sare al for esophageal varices， and one tr巴atmentcourse was completed by 
2 -4 procedures of EIS. 
Methods 
EIS was performed using an Olympus GIF-Qlo flexible endoscope (Olympus， Tokyo， Japan) 
under X -ray monitoring in the absence of a balloon， and 5 % ethanolamine oleate containing 
49 % Iopamidol (EOI) was used as the sclerosant. An endoscope was fixed at the retroflexion 
position， and a puncture was made. A disposable twenty-five gauge needle wearing an outer 
tube with a side hole (obtained from Top Corporation， Tokyo， Japan) was used for the 
puncture. The technique for controlling bleeding from the punctured site is illustrated in Fig. 
1. Following the intravariceal injection (A)， thrombin was poured into the outer tube through 
the side hole and the needle was gradually pulled out while injecting a small amountof EOI (B). 
After the needle was pulled out， the punctured site was pressed with the outer tube for a few 
seconds (C). When bleeding was negligible， thrombin was sprayed over the punctured site (D). 
If bleeding was stil noted， 1-2 ml of ethanol was injected (E). The volume of injected EOI was 
limited to 5 ml per injection and 10 ml per session on the basis of my experiences with the safety 
of injected EOI in patients with esophageal varices accompanied by shunt vessels. During the 
EIS， vasopressin (0.4 unit/min) was intravenously infused， and its infusion (0.1 unit/min) was 
Prophylactic endoscopic injection sc1erotherapy for gastric varices (651) 
continued until 24 h after the EIS. For 4 days after EIS， 5 % sodium alginate (200 ml/day) and 
thrombin (4 million unit/day) were given per os， and cimetidine (400 mg/day) and sorcoseryl 
(4 ml/day) wereadministered intravenously. Except for the usual premedications， no other 
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Fig. 1. Technique for controlling bleeding from the punctur巴dsite. 
RESULTS 
The number of EIS and volumes of injected EOIs are shown in Table 2. The mean number 
of EIS， meantotal volume of injected EOI per case and mean volume of injected EOI per one 
EIS were 1.9， 8.9 ml and 4.7 ml， respectively. Endoscopic findings of gastric varices before and 
after EIS are shown in Table 3. The findings before EIS were observed at the first EIS in each 
case， and those after EIS were observed 4 weeks after the last EIS. Marked improvements 
were observed in the findings in al cases. For example， nodular varices on the posterior wall 
and greater curvature observed in Case 5 and 6 had disappeared after EIS (Figs.2 A and 2 B). 
Complications of EIS， which were evaluated by clinical signs， laboratory data， ultrasonogram 
and endoscopy， are summarized in Table 4. The bleeding from the punctured site was 
Table 2. Number of EIS and volumes of injected sc1erosants 
Case NO. 
l 2 3 4 5 6 7 8 9 10 
Numb巴rof EIS I 2 1 I 3 2 1 2 3 3 
14 14 14 
7 EIS int巴rval(days) 19 45 21 7 7 
Total volume of 4.4 4.6 3.6 5.0 12.8 16.5 5.0 5. 5 15 . 0 17. 0 sc1巴rosant(mI)
Mean volum巴ofsc1erosant 4.4 2.3 3目6 5.0 4.3 8.3 5.0 2.8 5.0 5.7 per one EIS (mI) 
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Fig. 2A. Endoscopic findings of gastric varices in Case 5 before and after EIS 
Fig. 2B. Endoscopic findings of gastric varices in Case 6 b巴foreand after EIS. 
successfully controlled by the technique described in Methods. Ethanol injection for evident 
bleeding was required only in 2 out of 19 EIS procedures. N 0 other serious complications were 
observed， and thus no special treatment was required. Recurrent growth of gastric varices or 
variceal bleeding has not been observed in the cases Cfor 4 to 30 months) after the last EIS. 
Except for Case 1， who died of hepatic failure 10 months after EIS， al cases had survived. 
DISCUSSION 
Prophylactic treatment for gastric varices depends mainly on invasive procedures such as 
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Table 3. Endoscopic findings of gastric varices befor巴 andafter EIS 
Case NO. 
l 2 3 4 5 6 7 8 9 10 
Befor巴 EIS
Ant巴riorwall and 
十 十 十 十件 十 十lesser curvatur巴
Posterior wall and 
十仲 」一 十件 十社 イ十 十H 十件 十けgreater curvature 
EG junction +仲 十片 +仲
After EIS 
Anterior wall and 
十 十 土l巴sercurvature 
Posterior wall and ± gr巴ater curva ture 
十 + 
EG junction 十 土
十件 ; nodular or tumorous， 件 ; rosary， +; tortuous or arborescent， 士 ; flattend， 
disappeared， EG junction ; esophagogastric mucosal junction. 
The findings b巴foreEIS w巴reobserved at the first EIS in each case， and those after EIS w巴re
observed 4 weeks after the last EIS目
Table 4. Complications of EIS 
Anterior chest pain 




















Complications were evaluated by c1inical signs， 
laboratory data， ultrasonogram and endoscopy in 4 
weeks aft巴rthe last EIS 
surgery. In this study， 1 demonstrated that prophylactic EIS for gastric varices， a less invasive 
procedure， can be performedsafely to produce satisfactory results. Controlling bleeding from 
the punctured site is the most important problem in the EIS for gastric varices. By the 
iotravariceal injection method， compression of the punctured site by a balloon tamponade is 
difficult. The paravariceal injection method may be considered as another selection of EIS for 
gastric varices， but it is known that this method has litle efficacy on sc1erosing， and there is 
a higher risk of bleeding or perforation due to ulceration which is highly complicated by this 
method. In order to overcome the difficulty in the intravariceal injection method， 1 developed 
a new technique to prevent bleeding from the punctured site while pulling out the needle. 
Bleeding was minimized by simultaneous injection of a small amount of EOI when pulling out 
the needle. Following a brief compression on the punctured site with the outer tube fil1ed by 
thrombin， 1 added a thrombin-spraying and/or an ethanol injection. Thrombin-spraying was 
effective for negligible bleeding in most sessions. Even evident bleeding was well controlled by 
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ethanol injection. 
Another important problem is safety and efficacy of sclerosant for gastric varices. Unlike 
esophageal varices， intravariceal blood-flow is hardly interrupted with a balloon and the 
injected sclerosant apparently enters the systemic circulation easily in a case with gastric 
varices. Thus， a thrombus sufficient to give sclerosing effect is hardly obtained， and complica. 
tions in the systemic circulation may occur. Ethanolamine oleate is a safe material for EIS， 
because it is easily inactivated when it is combined with albumin in the systemic circulation6). 
From my previous observations in patients with esophageal varices accompanied by shunt 
vessels， 1 have noted that an injection of EOI limited to 5 ml per injection never induced any 
complication in the systemic circulation. 1 confirmed this fact in the present study on patients 
with gastric varices as well. For safety， it is beUer to confirm that the sclerosant was correctly 
infused into varices under X -ray monitoring. As for the efficacy of EOI， the injurious action 
of the injected EOI on the intravariceal endothelial cells was proved to be immediate and 
sufficient for thrombus to be formed. Kitano et al reported that EOI induced more complete 
thrombosis in the esophageal varices than polidocanoF). 
In summary， by improving the method of EIS and using EOI as a sclerosant 1 could safely 
treat gastric varices. Almost al varices disappeared or flaUened without any serious complica田
tion. Long-term observation of these cases revealed no bleeding and no new growing of gastric 
varices after EIS. From these results 1 concluded that EIS by this method is promising for 
managing risky gastric varices. 
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